+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

From
From
EPIDIOLEX Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

EPIDIOLEX Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
From
Neuropathic Pain Market and Forecast Analysis to 2026 - Product Thumbnail Image

Neuropathic Pain Market and Forecast Analysis to 2026

  • Report
  • October 2018
  • 293 Pages
  • Global
From
Global Krabbe Disease Treatment Market 2022-2026 - Product Thumbnail Image

Global Krabbe Disease Treatment Market 2022-2026

  • Report
  • April 2022
  • 120 Pages
  • Global
From
From
From
Seizures Global Clinical Trials Review, H1, 2020 - Product Thumbnail Image

Seizures Global Clinical Trials Review, H1, 2020

  • Clinical Trials
  • May 2020
  • 878 Pages
  • Global
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more